| Walgreens #3112 | |
| 1425 Massachusetts Ave, Arlington, Massachusetts 02476 | |
| (781) 646-3869 |
| Name | Walgreens #3112 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1425 Massachusetts Ave, Arlington, Massachusetts 02476 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (781) 646-3869 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching an Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists and clinicians to explore together how drugs work in complex systems.
Health departments nationwide scaled back their contact tracing in late spring or early summer when covid-19 cases started to decrease as vaccination efforts took center stage.
Results of a clinical trial released today in STEM CELLS Translational Medicine indicate that a combination of stem cell therapy and educational intervention can significantly help children with autism spectrum disorder (ASD).
Exelixis, Inc. announced today that it has entered into two new collaboration agreements with Bristol-Myers Squibb Company. Under the first agreement, Exelixis will grant to Bristol-Myers Squibb an exclusive license to its small-molecule TGR5 agonist program including backups.
University of Illinois at Chicago researchers received $2.9 million from the National Institute of Diabetes and Digestive and Kidney Diseases to study the outcomes of patients with sleep apnea and chronic kidney disease.
› Verified 3 days ago
| NPI Number | 1538174743 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #03112 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1425 Massachusetts Ave, Arlington, MA 02476 |
| Phone Number | 781-646-3869 |
News Archive
Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching an Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists and clinicians to explore together how drugs work in complex systems.
Health departments nationwide scaled back their contact tracing in late spring or early summer when covid-19 cases started to decrease as vaccination efforts took center stage.
Results of a clinical trial released today in STEM CELLS Translational Medicine indicate that a combination of stem cell therapy and educational intervention can significantly help children with autism spectrum disorder (ASD).
Exelixis, Inc. announced today that it has entered into two new collaboration agreements with Bristol-Myers Squibb Company. Under the first agreement, Exelixis will grant to Bristol-Myers Squibb an exclusive license to its small-molecule TGR5 agonist program including backups.
University of Illinois at Chicago researchers received $2.9 million from the National Institute of Diabetes and Digestive and Kidney Diseases to study the outcomes of patients with sleep apnea and chronic kidney disease.
› Verified 3 days ago
News Archive
Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching an Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists and clinicians to explore together how drugs work in complex systems.
Health departments nationwide scaled back their contact tracing in late spring or early summer when covid-19 cases started to decrease as vaccination efforts took center stage.
Results of a clinical trial released today in STEM CELLS Translational Medicine indicate that a combination of stem cell therapy and educational intervention can significantly help children with autism spectrum disorder (ASD).
Exelixis, Inc. announced today that it has entered into two new collaboration agreements with Bristol-Myers Squibb Company. Under the first agreement, Exelixis will grant to Bristol-Myers Squibb an exclusive license to its small-molecule TGR5 agonist program including backups.
University of Illinois at Chicago researchers received $2.9 million from the National Institute of Diabetes and Digestive and Kidney Diseases to study the outcomes of patients with sleep apnea and chronic kidney disease.
› Verified 3 days ago
Cvs Pharmacy # 00130 Type: Medicare Supplier Location: 23-25 Massachusetts Avenue, Arlington, Massachusetts 02474 Phone: (781) 648-0557 | |
Cvs Pharmacy # 00278 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 833 Massachusetts Avenue, Arlington, Massachusetts 02476 Phone: (781) 643-4272 | |
Stop & Shop Pharmacy #776 Type: Medicare Supplier Location: 905 Massachusetts Ave, Arlington, Massachusetts 02476 Phone: (781) 634-3267 | |
Walgreens #3112 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1425 Massachusetts Ave, Arlington, Massachusetts 02476 Phone: (781) 646-3869 | |
Walgreens #1864 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 324 Massachusetts Ave, Arlington, Massachusetts 02474 Phone: (781) 643-4110 |